Supplementing with palmitic acid, the end‐product of FASN‐catalysed lipid biosynthesis, reversed the TVB‐2640‐induced growth inhibition in KAR cancer cells, but had no effect on KPC cells (Figure 5H). Here, FASN is linked to cancer.